Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Invested Capital: 2019-2025

Historic Return on Invested Capital for Bicycle Therapeutics (BCYC) over the last 5 years, with Sep 2025 value amounting to -0.45%.

  • Bicycle Therapeutics' Return on Invested Capital fell 23.00% to -0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.45%, marking a year-over-year decrease of 23.00%. This contributed to the annual value of -0.35% for FY2024, which is 24.00% up from last year.
  • Per Bicycle Therapeutics' latest filing, its Return on Invested Capital stood at -0.45% for Q3 2025, which was down 11.75% from -0.40% recorded in Q2 2025.
  • Bicycle Therapeutics' Return on Invested Capital's 5-year high stood at -0.22% during Q3 2024, with a 5-year trough of -0.49% in Q1 2024.
  • Over the past 3 years, Bicycle Therapeutics' median Return on Invested Capital value was -0.36% (recorded in 2025), while the average stood at -0.36%.
  • Per our database at Business Quant, Bicycle Therapeutics' Return on Invested Capital climbed by 25bps in 2021 and then dropped by 23bps in 2025.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Return on Invested Capital stood at -0.25% in 2021, then increased by 7bps to -0.33% in 2022, then reached -0.48% in 2023, then rose by 23bps to -0.25% in 2024, then decreased by 23bps to -0.45% in 2025.
  • Its Return on Invested Capital stands at -0.45% for Q3 2025, versus -0.40% for Q2 2025 and -0.32% for Q1 2025.